Your browser doesn't support javascript.
loading
Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST.
Teranishi, Ryugo; Takahashi, Tsuyoshi; Nishida, Toshirou; Kurokawa, Yukinori; Nakajima, Kiyokazu; Koh, Masahiro; Nishigaki, Takahiko; Saito, Takuro; Yamamoto, Kazuyoshi; Yamashita, Kotaro; Tanaka, Koji; Makino, Tomoki; Motoori, Masaaki; Omori, Takeshi; Hirota, Seiichi; Hayashi, Yoshito; Takehara, Tetsuo; Eguchi, Hidetoshi; Doki, Yuichiro.
Afiliación
  • Teranishi R; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Takahashi T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan. ttakahashi2@gesurg.med.osaka-u.ac.jp.
  • Nishida T; Department of Surgery, Japan Community Health Care Organization Osaka Hospital, 4-2-78, Fukushima, Fukushima-Ku, Osaka, Japan.
  • Kurokawa Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nakajima K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Koh M; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nishigaki T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Saito T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Yamamoto K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Yamashita K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tanaka K; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Makino T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Motoori M; Department of Surgery, Osaka General Medical Center, 3-1-56, Bandai-Higashi, Sumiyoshi-Ku, Osaka, Osaka, 558-8558, Japan.
  • Omori T; Department of Surgery, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-Ku, Osaka, Osaka, 541-8567, Japan.
  • Hirota S; Department of Surgical Pathology, Hyogo Medical University School of Medicine, 1-1, Mugogawa-Cho, Nishinomiya, Hyogo, 663-8501, Japan.
  • Hayashi Y; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Takehara T; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Eguchi H; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Int J Clin Oncol ; 28(5): 680-687, 2023 May.
Article en En | MEDLINE | ID: mdl-36971916

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Tumores del Estroma Gastrointestinal / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Monitoreo de Drogas / Tumores del Estroma Gastrointestinal / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón